BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 26920602)

  • 21. Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices.
    Cano O; Muñoz B; Tejada D; Osca J; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A
    Heart Rhythm; 2012 Mar; 9(3):361-7. PubMed ID: 22001709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleeding risk of submuscular ICD implantation with continued oral anticoagulation versus heparin bridging therapy.
    Pecha S; Ayikli A; Wilke I; Hakmi S; Yildirim Y; Gosau N; Reichenspurner H; Willems S; Aydin MA
    Heart Vessels; 2018 Apr; 33(4):441-446. PubMed ID: 29030709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial.
    Flaker G; Lopes RD; Hylek E; Wojdyla DM; Thomas L; Al-Khatib SM; Sullivan RM; Hohnloser SH; Garcia D; Hanna M; Amerena J; Harjola VP; Dorian P; Avezum A; Keltai M; Wallentin L; Granger CB;
    J Am Coll Cardiol; 2014 Oct; 64(15):1541-50. PubMed ID: 25301455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial.
    Essebag V; Proietti R; Birnie DH; Wang J; Douketis J; Coutu B; Parkash R; Lip GYH; Hohnloser SH; Moriarty A; Oldgren J; Connolly SJ; Ezekowitz M; Healey JS
    Europace; 2017 Oct; 19(10):1630-1636. PubMed ID: 28339794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implanting cardiac rhythm devices during uninterrupted warfarin therapy: a prospective, single center experience.
    Crosato M; Calzolari V; Franceschini Grisolia E; Daniotti A; Baldessin F; Mantovan R; Olivari Z
    J Cardiovasc Med (Hagerstown); 2015 Jul; 16(7):503-6. PubMed ID: 25022924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
    Douketis JD; Healey JS; Brueckmann M; Eikelboom JW; Ezekowitz MD; Fraessdorf M; Noack H; Oldgren J; Reilly P; Spyropoulos AC; Wallentin L; Connolly SJ
    Thromb Haemost; 2015 Mar; 113(3):625-32. PubMed ID: 25472710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation.
    Coyle D; Coyle K; Cameron C; Lee K; Kelly S; Steiner S; Wells GA
    Value Health; 2013 Jun; 16(4):498-506. PubMed ID: 23796283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversing Direct Oral Anticoagulants in Acute Intracranial Hemorrhage.
    Nestor MA; Boling B
    Crit Care Nurse; 2019 Jun; 39(3):e1-e8. PubMed ID: 31154337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design.
    Birnie D; Healey JS; Krahn A; Essebag V; Sivakumaran S; Tang A; Simpson C
    Curr Opin Cardiol; 2009 Jan; 24(1):82-7. PubMed ID: 19102040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices.
    Ghanbari H; Phard WS; Al-Ameri H; Latchamsetty R; Jongnarngsin K; Crawford T; Good E; Chugh A; Oral H; Bogun F; Morady F; Pelosi F
    Am J Cardiol; 2012 Nov; 110(10):1482-8. PubMed ID: 22906894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY; Larsen TB; Skjøth F; Rasmussen LH
    J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do novel anticoagulant agents increase the risk of perioperative complications during implantable cardiac rhythm device insertion?
    Davies RA; Perera NK; Orr Y
    Interact Cardiovasc Thorac Surg; 2017 Jan; 24(1):126-128. PubMed ID: 27600911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of novel oral anticoagulants in catheter ablation of atrial fibrillation.
    Hansen PS; Sanchez R; Walfridsson H
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
    Healey JS; Eikelboom J; Douketis J; Wallentin L; Oldgren J; Yang S; Themeles E; Heidbuchel H; Avezum A; Reilly P; Connolly SJ; Yusuf S; Ezekowitz M;
    Circulation; 2012 Jul; 126(3):343-8. PubMed ID: 22700854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.
    Jamula E; Douketis JD; Schulman S
    J Thromb Haemost; 2008 Oct; 6(10):1615-21. PubMed ID: 18638011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedure.
    Li HK; Chen FC; Rea RF; Asirvatham SJ; Powell BD; Friedman PA; Shen WK; Brady PA; Bradley DJ; Lee HC; Hodge DO; Slusser JP; Hayes DL; Cha YM
    Pacing Clin Electrophysiol; 2011 Jul; 34(7):868-74. PubMed ID: 21410724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac rhythm device surgery with uninterrupted oral anticoagulation.
    Tyagi G; Pai SM; Pai RG
    Future Cardiol; 2013 Nov; 9(6):763-6. PubMed ID: 24180532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost effectiveness of continued-warfarin versus heparin-bridging therapy during pacemaker and defibrillator surgery.
    Coyle D; Coyle K; Essebag V; Birnie DH; Ahmad K; Toal S; Sapp J; Healey JS; Verma A; Wells G; Krahn AD
    J Am Coll Cardiol; 2015 Mar; 65(9):957-9. PubMed ID: 25744016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.